IPSC · Company research

Century Therapeutics, Inc. Common Stock (IPSC): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20261.28$323,103,104.71272055104.712.8823529411764706———1.2204359861224428—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.